HD-OPM Archive
Topics › GLP-1 drugs (semaglutide, tirzepatide)

About 4% of Americans on GLP-1 drugs in 2024

Gokhan Can · May 27, 2025 · ♥ 4 reactions · 5 comments · original Facebook post
GLP-1 drugs (semaglutide, tirzepatide)Weight, visceral & liver fat
AI summary & key facts

Gokhan notes Axios data that around 4% of Americans used GLP-1 drugs in 2024 and says GLP-1 drugs lowered MACE and mortality in RCTs in people with obesity. No specific trial is named.

~4% of Americans were on GLP1 in 2024. That's a lot of people :) The good thing is that this drug was literally shown to lower MACE and all cause mortality in RCTs involving obese. I think it's a natural choice if you're struggling with chronic obesity.

axios.comAmerican glp1 use weight loss increasingThe data shows the explosion in use of the drugs for weight loss.axios.com
#glp1#mortality#obesity
← newer: Looking healthy on keto or carnivore does not rule out silenolder: Short endorsement of an image post, acknowledged as not seri →